- Home
- SCTX vs MTA Comparison
SCTX vs MTA Comparison
Compare SCTX & MTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCTX | MTA |
|---|---|---|
| Founded | N/A | 1983 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.5M | 636.3M |
| IPO Year | 2026 | 2017 |
Fundamental Metrics
Financial Performance| Metric | SCTX | MTA |
|---|---|---|
| Price | $31.34 | $10.21 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 208.5K | ★ 574.3K |
| Earning Date | N/A | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $81.63 |
| Revenue Next Year | N/A | $62.44 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.31 | $5.31 |
| 52 Week High | $39.60 | $11.60 |
Technical Indicators
Market Signals| Indicator | SCTX | MTA |
|---|---|---|
| Relative Strength Index (RSI) | 57.35 | 55.66 |
| Support Level | $27.20 | $7.29 |
| Resistance Level | $39.60 | $11.60 |
| Average True Range (ATR) | 4.68 | 0.52 |
| MACD | -0.24 | -0.16 |
| Stochastic Oscillator | 37.82 | 23.88 |
Price Performance
Historical ComparisonAbout SCTX Scribe Therapeutics Inc. Common Stock
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
About MTA Metalla Royalty & Streaming Ltd.
Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company that engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests. Geographically, the company generates revenue from Australia, Brazil, Mexico, and the USA, with the majority generated from Brazil.